ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization
In: PR Newswire Asia, 2023-06-07, S. 2
Zeitungsartikel
Zugriff:
TOKYO, June 7, 2023 /PRNewswire/ -- Cell and gene therapy (CGT) is a cutting-edge therapy that combats cancer by bolstering the immune system through stem cell infusions or modified immune cells. However, manufacturing cell therapies is no easy feat. To support the commercialization of cell therapies, ACROBiosystems is now offering a global custom GMP-grade protein services...
Titel: |
ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization
|
---|---|
Zeitschrift: | PR Newswire Asia, 2023-06-07, S. 2 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|